Cypress Capital Management (Wyoming)’s Clovis Oncology, Inc. CLVS Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-200	Closed	–	–	183
2022 Q2	$0	Sell	200 -1,800	-90%	–	﹤0.01%	197
2022 Q1	$4K	Hold	2,000	–	–	﹤0.01%	148
2021 Q4	$5K	Hold	2,000	–	–	﹤0.01%	227
2021 Q3	$9K	Hold	2,000	–	–	0.01%	186
2021 Q2	$12K	Hold	2,000	–	–	0.01%	210
2021 Q1	$14K	Hold	2,000	–	–	0.01%	183
2020 Q4	$10K	Hold	2,000	–	–	0.01%	174
2020 Q3	$11K	Hold	2,000	–	–	0.01%	152
2020 Q2	$14K	Hold	2,000	–	–	0.01%	141
2020 Q1	$13K	Hold	2,000	–	–	0.02%	123
2019 Q4	$21K	Buy	2,000 +1,150	+135%	+$12.1K	0.02%	125
2019 Q3	$3K	Hold	850	–	–	﹤0.01%	178
2019 Q2	$13K	Hold	850	–	–	0.02%	177
2019 Q1	$21K	Hold	850	–	–	0.03%	150
2018 Q4	$15K	Hold	850	–	–	0.03%	198
2018 Q3	$25K	Sell	850 -650	-43%	-$19.1K	0.03%	206
2018 Q2	$68K	Hold	1,500	–	–	0.07%	146
2018 Q1	$79K	Sell	1,500 -300	-17%	-$15.8K	0.09%	126
2017 Q4	$122K	Sell	1,800 -250	-12%	-$16.9K	0.14%	110
2017 Q3	$169K	Buy	2,050 +1,500	+273%	+$124K	0.2%	82
2017 Q2	$51.5K	Hold	550	–	–	0.06%	119
2017 Q1	$35K	Sell	550 -450	-45%	-$28.7K	0.04%	146
2016 Q4	$41.9K	Hold	1,000	–	–	0.04%	138
2016 Q3	$36.1K	Buy	1,000 +150	+18%	+$5.41K	0.05%	127
2016 Q2	$11.7K	Sell	850 -150	-15%	-$2.06K	0.02%	168
2016 Q1	$19.2K	Sell	1,000 -21,910	-96%	-$421K	0.03%	149
2015 Q4	$802K	Buy	22,910 +3,210	+16%	+$112K	1.01%	25
2015 Q3	$1.81M	Buy	19,700 +7,400	+60%	+$681K	2.33%	11
2015 Q2	$1.08M	Buy	12,300 +10,525	+593%	+$925K	1.22%	25
2015 Q1	$132K	Hold	1,775	–	–	0.16%	82
2014 Q4	$99.4K	Buy	+1,775	New	+$99.4K	0.13%	88